Luo Sulan's resume
1999 graduated from Northwest A&F University and worked as a visiting scholar at Oxford University, Utah University and Queensland University, Australia. Engaged in teaching and scientific research in the field of marine medicine and biotechnology, and responsible for the establishment of biotechnology experimental center and pharmaceutical engineering specialty of Hainan University. As the project leader, he presided over more than 20 national major scientific and technological projects such as "major new drug creation". Three unknown new superfamily conotoxin with unique cysteine patterns were discovered for the first time. Four novel α -conotoxins that specifically bind to mammalian acetylcholine receptors (nAChRs) were screened and identified. The molecular drug target of LtIA and its mutant, as well as the interaction mechanism and action site with the drug target and its mutant have been discovered and discovered, which has attracted wide attention from colleagues at home and abroad. He has published more than 90 papers in domestic and foreign academic journals such as JBochem. Five invention patents were applied and two were authorized. He is also a peer reviewer of six international journals, such as BMC Mol Biol and PEPTIDES. Won the second prize of scientific and technological progress in Hainan Province. There are three national projects under study.